NCT06897527 2025-07-08A Study to Evaluate the Safety of Dostarlimab in Adult Participants in India With Recurrent or Advanced Endometrial Cancer (EC)GlaxoSmithKlinePhase 4 Not yet recruiting100 enrolled
NCT07013851 2025-06-10NADIAGrupo Español de Investigación en Cáncer de OvarioPhase 2 Not yet recruiting25 enrolled